The present disclosure relates to implantable medical devices. More particularly, the present disclosure relates to a medical device lead including an unifilar coiled cable configured to reduce electrode heating in MRI environments.
Magnetic resonance imaging (MRI) is a non-invasive imaging procedure that utilizes nuclear magnetic resonance techniques to render images within a patient's body. Typically, MRI systems employ the use of a magnetic coil having a magnetic field strength of between about 0.2 to 3 Teslas (T). During the procedure, the body tissue is briefly exposed to RF pulses of electromagnetic energy in a plane perpendicular to the magnetic field. The resultant electromagnetic energy from these pulses can be used to image the body tissue by measuring the relaxation properties of the excited atomic nuclei in the tissue.
During imaging, the electromagnetic radiation produced by the MRI system may be picked up by implantable device leads used in implantable medical devices such as pacemakers or cardiac defibrillators. This energy may be transferred through the lead to the electrode in contact with the tissue, which may lead to elevated temperatures at the point of contact. The degree of tissue heating is typically related to factors such as the length of the lead, the conductivity or impedance of the lead, and the surface area of the lead electrodes. Exposure to a magnetic field may also induce an undesired voltage on the lead.
Disclosed herein are various embodiments of a medical device lead including a small diameter unifilar coiled cable, as well as medical device systems including such a lead.
In Example 1, a medical device lead includes a flexible body having a proximal region with a proximal end, and a distal region with a distal end. A connector is coupled to the proximal end of the flexible body of the lead to electrically and mechanically connect the lead to an implantable pulse generator. The medical device lead also includes an electrode in the distal region of the flexible body, and a cable conductor having a proximal end electrically coupled to the connector and a distal end electrically coupled to the electrode. The cable conductor consists of a single helically coiled filar including a plurality of co-radial turns and having an outer diameter of less than about 0.020 inch (0.508 mm).
In Example 2, the medical device lead according to Example 1, wherein a pitch of the helically coiled filar is about one to about two times a diameter of the filar.
In Example 3, the medical device lead according to either Example 1 or 2, wherein the pitch of the helically coiled filar varies along at least a portion of the cable conductor.
In Example 4, the medical device lead according to any of Examples 1-3, wherein a diameter of the filar is less than about 0.003 inch (0.076 mm).
In Example 5, the medical device lead according to any of Examples 1-4, and further comprising a dielectric mandrel extending through and coaxially with the helically coiled filar.
In Example 6, the medical device lead according to any of Examples 1-5, wherein the flexible body comprises a plurality of lumens, and wherein the cable conductor extends through one of the plurality of lumens.
In Example 7, a medical device lead includes a flexible body having a proximal region with a proximal end and a distal region with a distal end. A connector is coupled to the proximal end of the flexible body of the lead to electrically and mechanically connect the lead to an implantable pulse generator. A tip electrode is at the distal end of the flexible body, and one or more ring electrodes are in the distal region of the flexible body. The medical device lead further includes a coiled conductor having a proximal end electrically coupled to the connector and a distal end electrically coupled to the tip electrode, and one or more cable conductors each having a proximal end electrically coupled to the connector and a distal end electrically coupled to one of the one or more ring electrodes. Each cable conductor consists of a single helically coiled filar including a plurality of co-radial turns. An outer diameter of each of the cable conductors is less than an outer diameter of the coiled conductor.
In Example 8, the medical device lead according to Example 7, wherein the outer diameter of each of the one or more cable conductors is less than about 0.020 inch (0.508 mm).
In Example 9, the medical device lead according to either Example 7 or 8, wherein, for each of the one or more cable conductors, a pitch of the helically coiled filar is about one to about two times a diameter of the filar.
In Example 10, the medical device lead according to any of Examples 7-9, wherein the pitch of the helically coiled filar of at least one of the one or more cable conductors varies along at least a portion of the cable conductor.
In Example 11, the medical device lead according to any of Examples 7-10, wherein, for each of the one or more cable conductors, a diameter of the filar is less than about 0.003 inch (0.076 mm).
In Example 12, the medical device lead according to any of Examples 7-11, and further comprising a dielectric mandrel extending through and coaxially with each helically coiled filar.
In Example 13, the medical device lead according to any of Examples 7-12, wherein the flexible body comprises a plurality of lumens, and wherein the coiled conductor and the one or more cable conductors extend through different lumens.
In Example 14, the medical device lead according to any of Examples 7-13, wherein the tip electrode comprises a fixation helix.
In Example 15, a medical device lead includes a flexible body having a proximal region with a proximal end, and a distal region with a distal end. A connector is coupled to the proximal end of the flexible body of the lead to electrically and mechanically connect the lead to an implantable pulse generator. One or more electrodes are in the distal region of the flexible body and are configured to deliver pacing signals and/or sense electrical activity of cardiac tissue. One or more cable conductors each have a proximal end electrically coupled to the connector and a distal end electrically coupled to one of the one or more electrodes. Each cable conductor consists of a single helically coiled filar including a plurality of co-radial turns. The outer diameter of each of the one or more cable conductors is less than about 0.020 inch (0.508 mm).
In Example 16, the medical device lead according to Example 15, wherein, for each of the one or more cable conductors, a pitch of the helically coiled filar is about one to about two times a diameter of the filar.
In Example 17, the medical device lead according to either Example 15 or 16, wherein the pitch of the helically coiled filar of at least one of the one or more cable conductors varies along at least a portion of the cable conductor.
In Example 18, the medical device lead according to any of Examples 15-17, wherein, for each of the one or more cable conductors, a diameter of the filar is less than about 0.003 inch (0.076 mm).
In Example 19, the medical device lead according to any of Examples 15-18, and further comprising a dielectric mandrel extending through and coaxially with each helically coiled filar.
In Example 20, the medical device lead according to any of Examples 15-19, wherein the filar comprises an insulative coating.
While multiple embodiments are disclosed, still other embodiments of the present invention will become apparent to those skilled in the art from the following detailed description, which shows and describes illustrative embodiments of the invention. Accordingly, the drawings and detailed description are to be regarded as illustrative in nature and not restrictive.
While the invention is amenable to various modifications and alternative forms, specific embodiments have been shown by way of example in the drawings and are described in detail below. The intention, however, is not to limit the invention to the particular embodiments described. On the contrary, the invention is intended to cover all modifications, equivalents, and alternatives falling within the scope of the invention as defined by the appended claims.
The distal region 20 of the lead 14 has an axially compact design that accommodates a dedicated bipolar electrode configuration. The lead 14 may alternatively have other electrode configurations. As will be explained in further detail herein and shown in additional figures, one or more conductors that electrically couple the connector in the proximal region 18 of the lead 14 to one or more electrodes in the distal region 20 of the lead 14 are configured to minimize energy pickup in MRI environments to reduce heating at the electrodes.
The pulse generator 12 typically includes a connector header 13 that couples the pulse generator 12 to the lead 14. The connector header 13 typically contains one or more bores 17 that is/are able to receive a connector (not shown) that is part of a connector assembly (not shown, but see 40 in
The connection header 13 can be attached to a hermetically sealed enclosure 15 that contains a battery, electronic circuitry, and other components known to those skilled in the art. Electrical contacts (not shown) in the connection header 13 can be a type known to those skilled in the art that are electrically connected via feedthroughs (not shown) mounted to extend through the hermetically sealed enclosure 15 in order to electrically couple the lead 14 with pulse generator 12.
The pulse generator 12 can be implanted subcutaneously within an implantation location or pocket in the patient's chest or abdomen. In embodiments in which the lead 14 is a neural lead, the pulse generator may alternatively be implanted at the patient's back or buttocks. The pulse generator 12 may be any implantable medical device known in the art or later developed, for delivering an electrical therapeutic stimulus to the patient. In various embodiments, the pulse generator 12 is a pacemaker, an implantable cardioverter/defibrillator (ICD), a cardiac resynchronization (CRT) device configured for bi-ventricular pacing, and/or includes combinations of pacing, CRT, and defibrillation capabilities.
The lead body 22 can be made from a flexible, biocompatible material suitable for lead construction. In various embodiments, the lead body 22 is made from a flexible, electrically insulative material. In one embodiment, the lead body 22 is made from silicone rubber. In another embodiment, the lead body 22 is made from polyurethane. In various embodiments, respective segments of the lead body 22 are made from different materials, so as to tailor the lead body 22 characteristics to its intended clinical and operating environments. In various embodiments, proximal and distal ends of the lead body 22 are made from different materials selected to provide desired functionalities.
The heart 16 includes a right atrium 26, a right ventricle 28, a left atrium 30 and a left ventricle 32. The heart 16 includes an endothelial inner lining or endocardium 34 covering the myocardium 36. In some embodiments as illustrated, the fixation helix 24, located at the distal region 20 of the lead, penetrates through the endocardium 34, and is imbedded within the myocardium 36. Alternatively, the lead 14 may be configured as a passive fixation lead as discussed herein. In one embodiment, the IMD 10 includes a plurality of leads 14. For example, it may include a first lead 14 adapted to convey electrical signals between the pulse generator 12 and the right ventricle 28, and a second lead (not shown) adapted to convey electrical signals between the pulse generator 12 and the right atrium 26. Additional leads may also be employed. For example, in various embodiments, a coronary venous lead (not shown) may be utilized for stimulating a left atrium 30 and/or a left ventricle 32 of the heart 16.
In the illustrated embodiment shown in
During operation, the lead 14 can be configured to convey electrical signals between the IMD 12 and the heart 16. For example, in those embodiments in which the IMD 12 is a pacemaker, the lead 14 can be utilized to deliver electrical stimuli for pacing the heart 16. In those embodiments in which the IMD 12 is an implantable cardiac defibrillator, the lead 14 can be utilized to deliver electric shocks to the heart 16 in response to an event such as a heart attack or arrhythmia. In some embodiments, the IMD 12 includes both pacing and defibrillation capabilities.
The electrical signals are carried between the IMD 12 and electrodes at the distal region 20 by one or more conductors extending through the lead 14. The one or more conductors are electrically coupled to a connector suitable for interfacing with the IMD 12 at the proximal region 18 of the lead 14 and to the one or more electrodes at the distal region 20. According to various embodiments, the one or more conductors include coiled cables consisting of a single filar and having a small outer diameter. In some embodiments, the coiled cables are configured to deliver low voltage signals to the one or more electrodes. The coil pitch may be small (e.g., one to two times the cable filar diameter) to minimize effects of magnetic resonance imaging (MRI) scans on the functionality and operation of the lead 14.
A distal assembly 46 is disposed at or near the distal region 20 or distal end of the lead 14 or lead body 22. Depending on the functional requirements of the IMD 10 (see
The distal assembly 46 includes a housing 50, within which the fixation helix 24, or helical electrode, is at least partially disposed. As will be explained in greater detail herein, the housing 50 accommodates a mechanism that enables the fixation helix 24 to move distally and proximally relative to the housing 50, but that includes structure (not seen in this view) that limits distal travel of the fixation helix 24 (relative to the housing 50) in order to reduce or prevent over-extension of the fixation helix 24. As noted herein, the fixation helix 24 operates as an anchoring means for anchoring the distal region 20 of the lead 14 within the heart 16. In alternative embodiments, the lead 14 is fixed relative to the heart 16 using passive structures (e.g., tines, spirals, etc.).
In some embodiments, the fixation helix 24, or helical electrode, is electrically active, and is used as a low-voltage, pace/sense electrode. In some embodiments, the fixation helix 24 is made of an electrically conductive material such as ELGILOY™, MP35N™, tungsten, tantalum, iridium, platinum, titanium, palladium, stainless steel as well as alloys of these materials.
The lead 14 is one exemplary implementation of a lead in accordance with the present disclosure, and other configurations for the lead 14 are also possible. For example, while coil electrodes 48, 49 are shown adjacent to each other, the coil electrode 49 may alternatively be disposed more proximally on the lead 14. As another example, the lead 14 may include a plurality of annular electrodes along the distal region 20 for providing pacing and/or sensing signals to adjacent tissue.
The coil conductor 60 is adapted for connection to the pulse generator 12 at the proximal region 18 of the lead 14. For example, the coil conductor 60 may be electrically connected to the connector 42. In the embodiment shown, the coil conductor 60 extends in parallel through the lead 14 with the coiled cable conductors 62, 64. The longitudinal axis of the coil conductor 60 is offset from the longitudinal axes of the coiled cable conductors 62, 64. In some embodiments, the coil conductor 60 is electrically coupled to one or more electrodes in the distal region 20 of the lead 14. For example, in some implementations the coil conductor 60 may be electrically coupled to the fixation helix 24 and/or the ring electrode 47. The coil conductor 60 may alternatively or additionally be connected to other electrodes. To reduce the amount of MRI-induced energy that is transmitted to the electrodes connected to the coil conductor 60, the turns of the coil conductor 60 may be tightly wound to maximize the inductance of the coil. In some embodiments, to minimize the space between adjacent turns and maximize the number of turns, the coil conductor 60 is unifilar. In other embodiments, the coil conductor 60 is multifilar.
The coiled cable conductors 62, 64 are also adapted for connection to the pulse generator 12 at the proximal region 18 of the lead 14, for example via electrical connection to the connector 42. In some embodiments, the coiled cable conductors 62, 64 are configured to carry low voltage signals between the pulse generator 12 and one or more electrodes in the distal region 20. For example, with regard to the embodiment of the lead 14 shown in
While two coiled cable conductors 62, 64 are shown, the lead 14 may alternatively include any number of coiled cable conductors 62, 64. For example, in one alternative configuration, the lead 14 includes four cable conductors, each connected to one of the proximal or distal ends of the coil electrodes 48, 49. In another alternative configuration, the lead 14 includes a plurality of annular electrodes in the distal region, and a coiled cable conductor is connected to each of the plurality of annular electrodes.
Exposure of the lead 14 to magnetic resonance imaging (MRI) fields can result in localized heating of the electrodes at the distal region 18 due to excitation of the lead conductors (e.g., coiled cable conductors 62, 64). Conductors with high inductance (>1 μH) are more resistant to excitation in MRI fields. The inductance of the conductor is determined by its geometric properties, including whether the conductor is straight or coiled. For a coiled or wound conductor, such as the coiled cable conductors 62, 64, several parameters influence its inductance, including the coil pitch, the outer diameter of the coil 52, the cross-sectional area of the coil 52, and the number of filars comprising the coil 52. For example, in some embodiments, the coil pitch (i.e., the distance between the centers of adjacent coil turns) may be small (e.g., one to two times the cable filar diameter). The conductive coil 62 is shown having a pitch of approximately equal to the filar diameter in
The coiled cable conductors 62, 64 may have an outer diameter d of less than about 0.020 inch (0.508 millimeter (mm)). For example, in some exemplary implementations, the outer diameter d of the coiled cable conductors 62, 64 are in the range of about 0.008 inch to about 0.014 inch (0.203-0.356 mm). In some embodiments, the coiled cable conductors 62, 64 each consist of a single filar of conductive material (i.e., unifilar) that is helically coiled with a plurality of co-radial turns. The turns of the coiled cable conductors 62, 64 may be closely wound. For example, in some embodiments, the coiled cable conductors 62, 64 have a pitch of between about one and two times the filar diameter. The pitch may be consistent along the length of the coiled cable conductors 62, 64, or may be varied along at least a portion of the coiled cable conductors 62, 64. One exemplary approach to incorporating variable pitch sections into the coiled cable conductors 62, 64 is described in U.S. Publication 2009/0149933, entitled “Implantable Lead Having a Variable Coil Conductor Pitch,” which is hereby incorporated by reference in its entirety. In some embodiments, the filar of the coiled cable conductors 62, 64 has a diameter of between about 0.0007 inch and 0.003 inch (0.018-0.076 mm). One exemplary material suitable for coiled cable conductors 62, 64 is MP35N including a silver core. Other exemplary materials suitable for coiled cable conductors 62, 64 include, but are not limited to, MPTa (MP35N with tantalum), platinum-clad Ta, platinum-clad MP35N, MP35N, and Nitinol. In some embodiments, the filar of each of the coiled cable conductors 62, 64 is insulated.
A plurality of leads including unifilar coiled cable conductors as described were exposed to an MRI environment, and the heating at the electrode attached to each of the unifilar coiled cable conductors was measured. For comparison, similar leads including bifilar and trifilar coiled cable conductors were also exposed to an MRI environment, and the associated electrodes were tested for heating. In each case, the coiled cable conductors were connected to the distal end of the distal coil electrode (e.g., coil electrode 48 in
The coiled cable conductors 62, 64 with a small outer diameter d and having a small pitch may be prone to damage during construction and use. For example, unifilar coils, such as coiled cable conductors 62, 64, may not transmit torque well, and the forces typically encountered by the lead 14 can cause the coiled cable conductors 62, 64 to experience stress concentrations in portions of the coiled cable conductors 62, 64, which can lead to premature fatigue of the coiled cable conductors 62, 64. To prevent this from occurring, the coiled cable conductors 62 and/or 64 may be formed about a flexible, non-conductive mandrel 72 that is retained after manufacturing and during use. In some embodiments, the mandrel 72 is comprised of a polymeric material, such as expanded polytetrafluoroethylene (ePTFE), layered ePTFE, polytetrafluoroethylene (PTFE), polyethylene terephthalate (PETE), ethylene/tetrafluoroethylene copolymer (ETFE), fluorinated ethylene propylene (FEP), polyether ether ketone (PEEK), polyamides, polyimides, para-aramid synthetic fibers, and polyurethane. The mandrel 72 increases the axial pull strength of the coiled cable conductors 62, 64 for later manufacturing processes and during chronic implantation. That is, the mandrel 72 improves the strength of the coiled cable conductors 62, 64 with respect to forces along the longitudinal axes of the coiled cable conductors 62, 64. This improved axial pull strength is provided by the flexible and resilient mandrel 72 substantially filling the inner diameter of the coiled cable conductors 62, 64. During manufacturing, the coiled cable conductors 62, 64 may be wrapped around the mandrel 72 in a tightly-wound configuration. In alternative embodiments, the mandrel 72 is removed from the coiled cable conductors 62, 64 after manufacturing.
Various modifications and additions can be made to the exemplary embodiments discussed without departing from the scope of the present invention. For example, while the embodiments described above refer to particular features, the scope of this invention also includes embodiments having different combinations of features and embodiments that do not include all of the described features. Accordingly, the scope of the present invention is intended to embrace all such alternatives, modifications, and variations as fall within the scope of the claims, together with all equivalents thereof.
This application claims priority under 35 U.S.C. §119 to U.S. Provisional Application No. 61/636,204, filed on Apr. 20, 2012, entitled “Implantable Medical Device Lead Including A Unifilar Coiled Cable,” which is incorporated herein by reference in its entirety for all purposes.
Number | Name | Date | Kind |
---|---|---|---|
3614692 | Rozelle et al. | Oct 1971 | A |
4131759 | Felkel | Dec 1978 | A |
4135518 | Dutcher | Jan 1979 | A |
4404125 | Abolins et al. | Sep 1983 | A |
4437474 | Peers-Trevarton | Mar 1984 | A |
4484586 | McMickle et al. | Nov 1984 | A |
4493329 | Crawford et al. | Jan 1985 | A |
4643203 | Labbe | Feb 1987 | A |
4869970 | Gulla et al. | Sep 1989 | A |
5003975 | Hafelfinger et al. | Apr 1991 | A |
5056516 | Spehr | Oct 1991 | A |
5074313 | Dahl et al. | Dec 1991 | A |
5201865 | Kuehn | Apr 1993 | A |
5217010 | Tsitlik et al. | Jun 1993 | A |
5222506 | Patrick et al. | Jun 1993 | A |
5231996 | Bardy et al. | Aug 1993 | A |
5241957 | Camp et al. | Sep 1993 | A |
5243911 | Dow et al. | Sep 1993 | A |
5246014 | Williams et al. | Sep 1993 | A |
5324322 | Grill, Jr. et al. | Jun 1994 | A |
5330522 | Kreyenhagen | Jul 1994 | A |
5354327 | Smits | Oct 1994 | A |
5370666 | Lindberg et al. | Dec 1994 | A |
5378234 | Hammerslag et al. | Jan 1995 | A |
5387199 | Siman et al. | Feb 1995 | A |
5417208 | Winkler | May 1995 | A |
5425755 | Doan | Jun 1995 | A |
5456707 | Giele | Oct 1995 | A |
5476485 | Weinberg et al. | Dec 1995 | A |
5483022 | Mar | Jan 1996 | A |
5522872 | Hoff | Jun 1996 | A |
5522875 | Gates et al. | Jun 1996 | A |
5534018 | Wahlstrand et al. | Jul 1996 | A |
5545205 | Schulte et al. | Aug 1996 | A |
5549646 | Katz et al. | Aug 1996 | A |
5554139 | Okajima | Sep 1996 | A |
5574249 | Lindsay | Nov 1996 | A |
5584873 | Shoberg et al. | Dec 1996 | A |
5599576 | Opolski | Feb 1997 | A |
5609622 | Soukup et al. | Mar 1997 | A |
5618208 | Crouse et al. | Apr 1997 | A |
5727552 | Ryan | Mar 1998 | A |
5727553 | Saad | Mar 1998 | A |
5728149 | Laske et al. | Mar 1998 | A |
5755742 | Schuelke et al. | May 1998 | A |
5760341 | Laske et al. | Jun 1998 | A |
5766227 | Nappholz et al. | Jun 1998 | A |
5800496 | Swoyer et al. | Sep 1998 | A |
5810887 | Accorti, Jr. et al. | Sep 1998 | A |
5817136 | Nappholz et al. | Oct 1998 | A |
5824026 | Diaz | Oct 1998 | A |
5833715 | Vachon et al. | Nov 1998 | A |
5849031 | Martinez et al. | Dec 1998 | A |
5891114 | Chien et al. | Apr 1999 | A |
5891179 | Er et al. | Apr 1999 | A |
5935159 | Cross, Jr. et al. | Aug 1999 | A |
5957966 | Schroeppel et al. | Sep 1999 | A |
5957970 | Shoberg et al. | Sep 1999 | A |
5968087 | Hess et al. | Oct 1999 | A |
6016447 | Juran et al. | Jan 2000 | A |
6057031 | Breme et al. | May 2000 | A |
6078840 | Stokes | Jun 2000 | A |
6083216 | Fischer, Sr. | Jul 2000 | A |
6101417 | Vogel et al. | Aug 2000 | A |
6106522 | Fleischman et al. | Aug 2000 | A |
6141593 | Patag | Oct 2000 | A |
6143013 | Samson et al. | Nov 2000 | A |
6178355 | Williams et al. | Jan 2001 | B1 |
6192280 | Sommer et al. | Feb 2001 | B1 |
6208881 | Champeau | Mar 2001 | B1 |
6249708 | Nelson et al. | Jun 2001 | B1 |
6256541 | Heil et al. | Jul 2001 | B1 |
6259954 | Conger et al. | Jul 2001 | B1 |
6289250 | Tsuboi et al. | Sep 2001 | B1 |
6295476 | Schaenzer | Sep 2001 | B1 |
6304784 | Allee et al. | Oct 2001 | B1 |
6317633 | Jorgenson et al. | Nov 2001 | B1 |
6360129 | Ley et al. | Mar 2002 | B1 |
6400992 | Borgersen et al. | Jun 2002 | B1 |
6428537 | Swanson et al. | Aug 2002 | B1 |
6434430 | Borgersen et al. | Aug 2002 | B2 |
6456888 | Skinner et al. | Sep 2002 | B1 |
6493591 | Stokes | Dec 2002 | B1 |
6501991 | Honeck et al. | Dec 2002 | B1 |
6501994 | Janke et al. | Dec 2002 | B1 |
6510345 | Van Bentem | Jan 2003 | B1 |
6516230 | Williams et al. | Feb 2003 | B2 |
6526321 | Spehr | Feb 2003 | B1 |
6564107 | Bodner et al. | May 2003 | B1 |
6671554 | Gibson et al. | Dec 2003 | B2 |
6721600 | Jorgenson et al. | Apr 2004 | B2 |
6721604 | Robinson et al. | Apr 2004 | B1 |
6813251 | Garney et al. | Nov 2004 | B1 |
6850803 | Jimenez et al. | Feb 2005 | B1 |
6854994 | Stein et al. | Feb 2005 | B2 |
6866044 | Bardy et al. | Mar 2005 | B2 |
6906256 | Wang | Jun 2005 | B1 |
6909256 | Itabashi | Jun 2005 | B2 |
6920361 | Williams | Jul 2005 | B2 |
6925334 | Salys | Aug 2005 | B1 |
6949929 | Gray et al. | Sep 2005 | B2 |
6978185 | Osypka | Dec 2005 | B2 |
6993373 | Vrijheid et al. | Jan 2006 | B2 |
6999818 | Stevenson et al. | Feb 2006 | B2 |
6999821 | Jenney et al. | Feb 2006 | B2 |
7013180 | Dublin et al. | Mar 2006 | B2 |
7013182 | Krishnan | Mar 2006 | B1 |
7047075 | Stubbs | May 2006 | B2 |
7047083 | Gunderson et al. | May 2006 | B2 |
7050855 | Zeijlemaker et al. | May 2006 | B2 |
7113827 | Silvestri et al. | Sep 2006 | B2 |
7123013 | Gray | Oct 2006 | B2 |
7127294 | Wang et al. | Oct 2006 | B1 |
7135978 | Gisselberg et al. | Nov 2006 | B2 |
7138582 | Lessar et al. | Nov 2006 | B2 |
7158837 | Osypka et al. | Jan 2007 | B2 |
7174219 | Wahlstrand et al. | Feb 2007 | B2 |
7174220 | Chitre et al. | Feb 2007 | B1 |
7205768 | Schulz et al. | Apr 2007 | B2 |
7239916 | Thompson et al. | Jul 2007 | B2 |
7257449 | Bodner | Aug 2007 | B2 |
7289851 | Gunderson et al. | Oct 2007 | B2 |
7363090 | Halperin et al. | Apr 2008 | B2 |
7369898 | Kroll et al. | May 2008 | B1 |
7378931 | Odahara et al. | May 2008 | B2 |
7388378 | Gray et al. | Jun 2008 | B2 |
7389148 | Morgan | Jun 2008 | B1 |
7453344 | Maeda et al. | Nov 2008 | B2 |
7535363 | Gisselberg et al. | May 2009 | B2 |
7571010 | Zarembo et al. | Aug 2009 | B2 |
7610101 | Wedan et al. | Oct 2009 | B2 |
7630761 | Salo et al. | Dec 2009 | B2 |
7765005 | Stevenson | Jul 2010 | B2 |
7917213 | Bulkes et al. | Mar 2011 | B2 |
7953499 | Knapp et al. | May 2011 | B2 |
7986999 | Wedan et al. | Jul 2011 | B2 |
8103360 | Foster | Jan 2012 | B2 |
8145324 | Stevenson et al. | Mar 2012 | B1 |
8170688 | Wedan et al. | May 2012 | B2 |
8244346 | Foster et al. | Aug 2012 | B2 |
8255055 | Ameri | Aug 2012 | B2 |
8306630 | Stubbs et al. | Nov 2012 | B2 |
8332050 | Perrey et al. | Dec 2012 | B2 |
8335572 | Ameri | Dec 2012 | B2 |
8391994 | Foster et al. | Mar 2013 | B2 |
8401671 | Wedan et al. | Mar 2013 | B2 |
8666508 | Foster et al. | Mar 2014 | B2 |
8666512 | Walker et al. | Mar 2014 | B2 |
20020065544 | Smits | May 2002 | A1 |
20020072769 | Silvian et al. | Jun 2002 | A1 |
20020111664 | Bartig et al. | Aug 2002 | A1 |
20020128689 | Connelly et al. | Sep 2002 | A1 |
20020144720 | Zahorik et al. | Oct 2002 | A1 |
20030028231 | Partridge et al. | Feb 2003 | A1 |
20030050680 | Gibson et al. | Mar 2003 | A1 |
20030063946 | Williams et al. | Apr 2003 | A1 |
20030083723 | Wilkinson et al. | May 2003 | A1 |
20030083726 | Zeijlemaker et al. | May 2003 | A1 |
20030092303 | Osypka | May 2003 | A1 |
20030093136 | Osypka et al. | May 2003 | A1 |
20030093138 | Osypka et al. | May 2003 | A1 |
20030139794 | Jenney et al. | Jul 2003 | A1 |
20030140931 | Zeijlemaker et al. | Jul 2003 | A1 |
20030144705 | Funke | Jul 2003 | A1 |
20030144716 | Reinke et al. | Jul 2003 | A1 |
20030144718 | Zeijlemaker | Jul 2003 | A1 |
20030144719 | Zeijlemaker | Jul 2003 | A1 |
20030144720 | Villaseca et al. | Jul 2003 | A1 |
20030144721 | Villaseca et al. | Jul 2003 | A1 |
20030204217 | Greatbatch | Oct 2003 | A1 |
20040014355 | Osypka et al. | Jan 2004 | A1 |
20040064161 | Gunderson et al. | Apr 2004 | A1 |
20040064173 | Hine et al. | Apr 2004 | A1 |
20040064174 | Belden | Apr 2004 | A1 |
20040088033 | Smits et al. | May 2004 | A1 |
20040122490 | Reinke et al. | Jun 2004 | A1 |
20040153049 | Hewitt et al. | Aug 2004 | A1 |
20040162600 | Williams | Aug 2004 | A1 |
20040167442 | Shireman et al. | Aug 2004 | A1 |
20040172117 | Hill et al. | Sep 2004 | A1 |
20040193140 | Griffin et al. | Sep 2004 | A1 |
20040243210 | Morgan et al. | Dec 2004 | A1 |
20040267107 | Lessar et al. | Dec 2004 | A1 |
20050030322 | Gardos | Feb 2005 | A1 |
20050070972 | Wahlstrand et al. | Mar 2005 | A1 |
20050090886 | MacDonald et al. | Apr 2005 | A1 |
20050113676 | Weiner et al. | May 2005 | A1 |
20050113873 | Weiner et al. | May 2005 | A1 |
20050113876 | Weiner et al. | May 2005 | A1 |
20050136385 | Mann et al. | Jun 2005 | A1 |
20050177135 | Hildebrand et al. | Aug 2005 | A1 |
20050182471 | Wang | Aug 2005 | A1 |
20050197677 | Stevenson | Sep 2005 | A1 |
20050222642 | Przybyszewski et al. | Oct 2005 | A1 |
20050222656 | Wahlstrand et al. | Oct 2005 | A1 |
20050222657 | Wahlstrand et al. | Oct 2005 | A1 |
20050222658 | Hoegh et al. | Oct 2005 | A1 |
20050222659 | Olsen et al. | Oct 2005 | A1 |
20050246007 | Sommer et al. | Nov 2005 | A1 |
20050267556 | Shuros et al. | Dec 2005 | A1 |
20050272280 | Osypka | Dec 2005 | A1 |
20050283167 | Gray | Dec 2005 | A1 |
20060009819 | Przybyszewski | Jan 2006 | A1 |
20060030774 | Gray et al. | Feb 2006 | A1 |
20060037461 | Yasumura | Feb 2006 | A1 |
20060041293 | Mehdizadeh et al. | Feb 2006 | A1 |
20060041294 | Gray | Feb 2006 | A1 |
20060041296 | Bauer et al. | Feb 2006 | A1 |
20060089691 | Kaplan et al. | Apr 2006 | A1 |
20060089695 | Bolea et al. | Apr 2006 | A1 |
20060089696 | Olsen et al. | Apr 2006 | A1 |
20060093685 | Mower et al. | May 2006 | A1 |
20060105066 | Teague et al. | May 2006 | A1 |
20060106442 | Richardson et al. | May 2006 | A1 |
20060118758 | Wang et al. | Jun 2006 | A1 |
20060129043 | Ben-Jacob et al. | Jun 2006 | A1 |
20060167536 | Nygren et al. | Jul 2006 | A1 |
20060200218 | Wahlstrand | Sep 2006 | A1 |
20060229693 | Bauer et al. | Oct 2006 | A1 |
20060247747 | Olsen et al. | Nov 2006 | A1 |
20060247748 | Wahlstrand et al. | Nov 2006 | A1 |
20060252314 | Atalar et al. | Nov 2006 | A1 |
20060253180 | Zarembo et al. | Nov 2006 | A1 |
20060271138 | MacDonald | Nov 2006 | A1 |
20060293737 | Krishnan | Dec 2006 | A1 |
20070010702 | Wang et al. | Jan 2007 | A1 |
20070027532 | Wang et al. | Feb 2007 | A1 |
20070106332 | Denker et al. | May 2007 | A1 |
20070112398 | Stevenson et al. | May 2007 | A1 |
20070156205 | Larson et al. | Jul 2007 | A1 |
20070179577 | Marshall et al. | Aug 2007 | A1 |
20070179582 | Marshall et al. | Aug 2007 | A1 |
20070191914 | Stessman | Aug 2007 | A1 |
20070208383 | Williams | Sep 2007 | A1 |
20080009905 | Zeijlemaker | Jan 2008 | A1 |
20080033497 | Bulkes et al. | Feb 2008 | A1 |
20080039709 | Karmarkar | Feb 2008 | A1 |
20080049376 | Stevenson et al. | Feb 2008 | A1 |
20080051854 | Bulkes et al. | Feb 2008 | A1 |
20080057784 | Zarembo et al. | Mar 2008 | A1 |
20080058902 | Gray et al. | Mar 2008 | A1 |
20080125754 | Beer et al. | May 2008 | A1 |
20080129435 | Gray | Jun 2008 | A1 |
20080132985 | Wedan et al. | Jun 2008 | A1 |
20080132986 | Gray et al. | Jun 2008 | A1 |
20080140152 | Imran et al. | Jun 2008 | A1 |
20080154348 | Atalar et al. | Jun 2008 | A1 |
20080208290 | Phillips et al. | Aug 2008 | A1 |
20080243218 | Bottomley et al. | Oct 2008 | A1 |
20080262584 | Bottomley et al. | Oct 2008 | A1 |
20090005825 | MacDonald | Jan 2009 | A1 |
20090024180 | Kisker et al. | Jan 2009 | A1 |
20090024197 | Jensen | Jan 2009 | A1 |
20090099440 | Viohl | Apr 2009 | A1 |
20090099555 | Viohl et al. | Apr 2009 | A1 |
20090118610 | Karmarkar et al. | May 2009 | A1 |
20090149920 | Li et al. | Jun 2009 | A1 |
20090149933 | Ameri | Jun 2009 | A1 |
20090198314 | Foster et al. | Aug 2009 | A1 |
20090204171 | Ameri | Aug 2009 | A1 |
20090210022 | Powers | Aug 2009 | A1 |
20090270956 | Vase et al. | Oct 2009 | A1 |
20090281608 | Foster | Nov 2009 | A1 |
20100010602 | Wedan et al. | Jan 2010 | A1 |
20100016935 | Strandberg et al. | Jan 2010 | A1 |
20100103215 | Iriguchi | Apr 2010 | A1 |
20100106215 | Stubbs et al. | Apr 2010 | A1 |
20100114277 | Zhao et al. | May 2010 | A1 |
20100125320 | Polkinghorne et al. | May 2010 | A1 |
20100137928 | Duncan et al. | Jun 2010 | A1 |
20100174348 | Bulkes et al. | Jul 2010 | A1 |
20100234929 | Scheuermann | Sep 2010 | A1 |
20100249892 | Bulkes et al. | Sep 2010 | A1 |
20100331936 | Perrey et al. | Dec 2010 | A1 |
20110060394 | Poore | Mar 2011 | A1 |
20110079423 | Zhao et al. | Apr 2011 | A1 |
20110087299 | Ameri | Apr 2011 | A1 |
20110087302 | Ameri | Apr 2011 | A1 |
20110093054 | Ameri | Apr 2011 | A1 |
20110160805 | Erbstoeszer et al. | Jun 2011 | A1 |
20110160816 | Stubbs et al. | Jun 2011 | A1 |
20110160817 | Foster et al. | Jun 2011 | A1 |
20110160818 | Struve | Jun 2011 | A1 |
20110160828 | Foster et al. | Jun 2011 | A1 |
20110160829 | Foster et al. | Jun 2011 | A1 |
20110208280 | Li et al. | Aug 2011 | A1 |
20110218422 | Atalar et al. | Sep 2011 | A1 |
20110238146 | Wedan et al. | Sep 2011 | A1 |
20110288403 | Kondabatni et al. | Nov 2011 | A1 |
20120016451 | Struve et al. | Jan 2012 | A1 |
20120022356 | Olsen et al. | Jan 2012 | A1 |
20120035698 | Johnson et al. | Feb 2012 | A1 |
20120053662 | Foster et al. | Mar 2012 | A1 |
20120109270 | Foster | May 2012 | A1 |
20120143273 | Stubbs et al. | Jun 2012 | A1 |
20120161901 | Stevenson et al. | Jun 2012 | A1 |
20120179233 | Wedan et al. | Jul 2012 | A1 |
20120253340 | Stevenson et al. | Oct 2012 | A1 |
20120271394 | Foster et al. | Oct 2012 | A1 |
20130116764 | Walker et al. | May 2013 | A1 |
20130158641 | Foster et al. | Jun 2013 | A1 |
20130190849 | Perrey et al. | Jul 2013 | A1 |
20130190850 | Wedan et al. | Jul 2013 | A1 |
20140067030 | Walker et al. | Mar 2014 | A1 |
Number | Date | Country |
---|---|---|
1762510 | Apr 2006 | CN |
101039619 | Sep 2007 | CN |
0897997 | Feb 2003 | EP |
1594564 | Nov 2005 | EP |
1852810 | Nov 2007 | EP |
2004141679 | May 2004 | JP |
2005501673 | Jan 2005 | JP |
2005515852 | Jun 2005 | JP |
2005515854 | Jun 2005 | JP |
WO9606655 | Mar 1996 | WO |
WO03089045 | Oct 2003 | WO |
WO2004073791 | Sep 2004 | WO |
WO2006105066 | Mar 2006 | WO |
WO2006093685 | Sep 2006 | WO |
WO2007047966 | Apr 2007 | WO |
WO2007089986 | Aug 2007 | WO |
WO2007118194 | Oct 2007 | WO |
WO2008051122 | May 2008 | WO |
WO20090137186 | Nov 2009 | WO |
WO2010078552 | Jul 2010 | WO |
Entry |
---|
Gray, Robert W. et al., “Simple design changes to wires to substantially reduce MRI-induced heating at 1.5 T: implications for implanted leads”, Magnetic Resonance Imaging 23 (2005) 887-891. |
International Search Report and Written Opinion issued in PCT/US2008/085518 on Oct. 29, 2009, 15 pages. |
International Search Report and Written Opinion issued in PCT/US2009/032838, mailed May 4, 2009, 14 pages. |
International Search Report and Written Opinion issued in PCT/US2009/038629, mailed Jun. 29, 2009, 11 pages. |
International Search Report and Written Opinion issued in PCT/US2010/024062, mailed Sep. 27, 2010. |
International Search Report and Written Opinion issued in PCT/US2010/033686 on Aug. 10, 2010, 12 pages. |
International Search Report and Written Opinion issued in PCT/US2010/055130, mailed Mar. 10, 2011, 11 pages. |
International Search Report and Written Opinion issued in PCT/US2010/055653, mailed Feb. 1, 2011, 14 pages. |
International Search Report and Written Opinion issued in PCT/US2012/055673, mailed Dec. 13, 2012, 10 pages. |
Invitation to Pay Additional Fees and Partial Search Report, dated Aug. 17, 2009, issued in PCT/US2008/085533, 6 pages. |
Invitation to Pay Additional Fees and Partial Search Report, issued in PCT/US2010/024062, mailed May 7, 2010. |
Partial International Search Report issued in PCT/US2013/013432, mailed Jul. 17, 2013, 6 pages. |
Partial International Search Report issued in PCT/US2013/037432, mailed Jul. 17, 2013, 6 pages. |
“High Voltage Engineering and Testing, 2nd Edition”, edited by Hugh M. Ryan, Institution of Engineering and Technology, 2001, 15 pages. |
Avalanche Breakdown, Wikipedia Article, captured Apr. 6, 2010, [http://en.wikipedia.org/wiki/Avalanche—breakdown]. |
Basso, Christophe, “SPICE Model Simulates Spark-Gap Arrestor”, Electronics Design, Strategy, and News (EDN), Jul. 3, 1997, 4 pages. |
Citel Inc., Data Sheet, BH Series 2 Electrode Miniature Gas Discharge Tube Surge Arrester-8mm, May 14, 2009, 2 pages. |
Hayes, David L., Chapter 4, “Generator and Lead Selection” from book entitled “Cardiac Pacing and Defibrillation A Clinical Approach”, John Wiley & Sons, (c) 2000 Mayo Foundation, p. 129-157. |
International Search Report and Written Opinion issued in PCT/US2009/056843, mailed Dec. 29, 2009, 13 pages. |
International Search Report and Written Opinion issued in PCT/US2010/048620, mailed Apr. 5, 2011, 10 pages. |
International Search Report and Written Opinion issued in PCT/US2010/053223, mailed Dec. 27, 2010, 11 pages. |
International Search Report and Written Opinion issued in PCT/US2011/052541, dated Mar. 9, 2012, 22 pages. |
International Search Report and Written Opinion issued in PCT/US2013/037432, mailed Nov. 19, 2013, 17 pages. |
International Search Report and Written Opinion issued in PCT/US2013/057732, mailed Dec. 13, 2013, 11 pages. |
Partial International Search Report issued in PCT/US2011/052541, mailed Dec. 6, 2011, 4 pages. |
Static Spark Gap Analysis, captured Dec. 24, 2002, [http;//www.richieburnett.co.uk/static.html]. |
Number | Date | Country | |
---|---|---|---|
20130282093 A1 | Oct 2013 | US |
Number | Date | Country | |
---|---|---|---|
61636204 | Apr 2012 | US |